Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Den Europæiske Union - dansk - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).

Sitagliptin/Metformin "Krka" 50+1000 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin/metformin "krka" 50+1000 mg filmovertrukne tabletter

krka d.d. novo mesto - metforminhydrochlorid, sitagliptin - filmovertrukne tabletter - 50+1000 mg

Sitagliptin/Metformin "Sandoz" 50+1000 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin/metformin "sandoz" 50+1000 mg filmovertrukne tabletter

sandoz a/s - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg

Sitagliptin/Metformin "Glenmark" 50+1000 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin/metformin "glenmark" 50+1000 mg filmovertrukne tabletter

glenmark arzneimittel gmbh - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg

Vildagliptin/Metformin "AET" 50+850 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

vildagliptin/metformin "aet" 50+850 mg filmovertrukne tabletter

tiefenbacher gmbh - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg

Tandemact Den Europæiske Union - dansk - EMA (European Medicines Agency)

tandemact

cheplapharm arzneimittel gmbh - pioglitazon, glimepirid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - tandemact er indiceret til behandling af patienter med type-2 diabetes mellitus, som vis intolerance over for metformin eller til hvem metformin er kontraindiceret, og der er allerede behandlet med en kombination af pioglitazon og glimepirid.

Vipdomet Den Europæiske Union - dansk - EMA (European Medicines Agency)

vipdomet

takeda pharma a/s - alogliptin benzoat, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. triple kombinationsbehandling) som supplement til diæt og motion til forbedring af glykæmisk kontrol hos patienter, når insulin på en stabil dosis og metformin alene ikke giver tilstrækkelig glykæmisk kontrol.